RenovoRx (RNXT) Short Interest Ratio & Short Volume $1.29 +0.02 (+1.57%) (As of 05:19 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends RenovoRx Short Interest DataRenovoRx (RNXT) has a short interest of 88,500 shares, representing 0.38% of the float (the number of shares available for trading by the public). This marks a 1.72% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 50,471 shares to cover all short positions.Current Short Interest88,500 sharesPrevious Short Interest87,000 sharesChange Vs. Previous Month+1.72%Dollar Volume Sold Short$112,395.00Short Interest Ratio1.6 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares24,001,000 sharesFloat Size23,540,000 sharesShort Percent of Float0.38%Today's Trading Volume37,953 sharesAverage Trading Volume50,471 sharesToday's Volume Vs. Average75% Short Selling RenovoRx? Sign up to receive the latest short interest report for RenovoRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRNXT Short Interest Over TimeRNXT Days to Cover Over TimeRNXT Percentage of Float Shorted Over Time Ad InvestorPlaceWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warning RenovoRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202488,500 shares $112,395.00 +1.7%0.4%1.6 $1.27 11/15/202487,000 shares $94,830.00 +21.0%0.4%1.9 $1.09 10/31/202471,900 shares $71,756.20 -21.8%0.3%2.2 $1.00 10/15/202491,900 shares $90,990.19 -19.6%0.4%2.8 $0.99 9/30/2024114,300 shares $121,158.00 +121.9%0.5%3.4 $1.06 9/15/202451,500 shares $57,963.25 -5.3%0.2%1.6 $1.13 Get the Latest News and Ratings for RNXT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RenovoRx and its competitors with MarketBeat's FREE daily newsletter. 8/31/202454,400 shares $55,488.00 -11.1%0.2%1.3 $1.02 8/15/202461,200 shares $67,932.00 +3.4%0.3%1.4 $1.11 7/31/202459,200 shares $71,040.00 +7.8%0.3%1.4 $1.20 7/15/202454,900 shares $69,723.00 +24.8%0.2%1.4 $1.27 6/30/202444,000 shares $49,720.00 +13.7%0.2%0.8 $1.13 6/15/202438,700 shares $45,666.00 -37.2%0.2%0.7 $1.18 5/31/202461,600 shares $71,456.00 +21.3%0.3%1.6 $1.16 5/15/202450,800 shares $70,104.00 +28.9%0.2%1.4 $1.38 4/30/202439,400 shares $50,038.00 -39.9%0.2%1 $1.27 4/15/202465,500 shares $75,980.00 +274.3%0.5%1.4 $1.16 3/31/202417,500 shares $23,450.00 +12.2%0.1%0.3 $1.34 3/15/202415,600 shares $20,592.00 +129.4%0.2%0.2 $1.32 2/29/20246,800 shares $11,696.00 -47.3%0.1%0.1 $1.72 2/15/202412,900 shares $18,189.00 +69.7%0.2%0.1 $1.41 1/31/20247,600 shares $11,400.00 -78.2%0.1%0.1 $1.50 1/15/202434,900 shares $38,390.00 +156.6%0.4%0.4 $1.10 12/31/202313,600 shares $31,144.00 -80.7%0.2%0.2 $2.29 12/15/202370,600 shares $60,363.00 +215.2%0.8%1.8 $0.86 11/30/202322,400 shares $14,336.00 +16.1%0.3%1.1 $0.64 11/15/202319,300 shares $14,282.00 -45.0%0.2%1 $0.74 10/31/202335,100 shares $40,014.00 -10.0%0.4%1.7 $1.14 10/15/202339,000 shares $43,290.00 -10.8%0.4%1.5 $1.11 9/30/202343,700 shares $58,121.00 +33.2%0.5%1.1 $1.33 9/15/202332,800 shares $54,448.00 -17.2%0.4%0.1 $1.66 8/31/202339,600 shares $64,152.00 -43.9%0.5%0.1 $1.62 8/15/202370,600 shares $124,962.00 -23.1%0.8%0.1 $1.77 7/31/202391,800 shares $181,764.00 -47.7%1.1%0.2 $1.98 7/15/2023175,500 shares $377,325.00 +1,540.2%2.1%0.3 $2.15 6/30/202310,700 shares $24,182.00 +21.6%0.1%0 $2.26 6/15/20238,800 shares $19,712.00 -50.0%0.1%0.2 $2.24 5/31/202317,600 shares $32,912.00 +35.4%0.2%0.5 $1.87 5/15/202313,000 shares $28,990.00 -49.6%0.2%0.2 $2.23 4/30/202325,800 shares $80,754.00 -17.6%0.4%0.5 $3.13 4/15/202331,300 shares $87,640.00 -1.3%0.4%0.5 $2.80Wall St. Icon: “If you wait on this, it will already be too late” (Ad)If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warning 3/31/202331,700 shares $110,474.50 +173.3%0.4%0.5 $3.49 3/15/202311,600 shares $38,164.00 +31.8%0.2%0.2 $3.29 2/28/20238,800 shares $40,920.00 -63.8%0.1%0.1 $4.65 2/15/202324,300 shares $98,658.00 -28.1%0.3%0.6 $4.06 1/31/202333,800 shares $88,894.00 +44.4%0.5%0.8 $2.63 1/15/202323,400 shares $70,434.00 -10.3%0.3%0.7 $3.01 12/30/202226,100 shares $61,335.00 -18.7%0.4%1.3 $2.35 12/15/202232,100 shares $72,225.00 +124.5%0.4%2.1 $2.25 11/30/202214,300 shares $27,885.00 +107.3%0.2%1.4 $1.95 11/15/20226,900 shares $13,524.00 +15.0%0.1%0.6 $1.96 10/31/20226,000 shares $10,500.00 -10.5%0.1%0.4 $1.75 10/15/20226,700 shares $11,524.00 -46.4%0.1%0.4 $1.72 9/30/202212,500 shares $25,250.00 -22.4%0.2%0.7 $2.02 9/15/202216,100 shares $42,021.00 +3.9%0.2%0.9 $2.61 8/31/202215,500 shares $32,550.00 +9.9%0.2%0.9 $2.10 8/15/202214,100 shares $33,699.00 -37.3%0.2%0.9 $2.39 7/31/202222,500 shares $43,751.25 +64.2%0.3%1.5 $1.94 7/15/202213,700 shares $26,578.00 -50.2%0.2%0.8 $1.94 6/30/202227,500 shares $54,450.00 -27.3%0.4%1.1 $1.98 6/15/202237,800 shares $77,868.00 +29.5%0.6%1.2 $2.06 5/31/202229,200 shares $57,232.00 +13.2%0.5%0.5 $1.96 5/15/202225,800 shares $46,956.00 -6.9%0.4%0.4 $1.82 4/30/202227,700 shares $46,259.00 -49.5%0.4%0.4 $1.67 4/15/202254,900 shares $142,191.00 -12.4%0.9%0.8 $2.59 3/31/202262,700 shares $183,711.00 +85.0%1.0%0.9 $2.93 3/15/202233,900 shares $97,293.00 -58.2%0.6%0.3 $2.87 2/28/202281,100 shares $272,496.00 -33.4%1.3%0.6 $3.36 2/15/2022121,800 shares $473,802.00 +84.0%2.0%0.3 $3.89 1/31/202266,200 shares $219,784.00 -51.0%1.0%0 $3.32 1/15/2022135,100 shares $548,506.00 +1.8%2.0%0.1 $4.06 12/31/2021132,700 shares $642,268.00 No Change2.0%0 $4.84 RNXT Short Interest - Frequently Asked Questions What is RenovoRx's current short interest? Short interest is the volume of RenovoRx shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 88,500 shares of RNXT short. 0.38% of RenovoRx's shares are currently sold short. Learn More on RenovoRx's current short interest. What is a good short interest ratio for RenovoRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RNXT shares currently have a short interest ratio of 2.0. Learn More on RenovoRx's short interest ratio. What is a good short interest percentage for RenovoRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.38% of RenovoRx's floating shares are currently sold short. Is RenovoRx's short interest increasing or decreasing? RenovoRx saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 88,500 shares, an increase of 1.7% from the previous total of 87,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is RenovoRx's float size? RenovoRx currently has issued a total of 24,001,000 shares. Some of RenovoRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. RenovoRx currently has a public float of 23,540,000 shares. How does RenovoRx's short interest compare to its competitors? 0.38% of RenovoRx's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to RenovoRx: Acumen Pharmaceuticals, Inc. (3.09%), Metagenomi, Inc. (1.45%), Leap Therapeutics, Inc. (4.97%), Protara Therapeutics, Inc. (14.64%), INmune Bio, Inc. (16.73%), X4 Pharmaceuticals, Inc. (7.33%), Adverum Biotechnologies, Inc. (11.10%), Cardiol Therapeutics Inc. (1.46%), MediciNova, Inc. (0.72%), Journey Medical Co. (0.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short RenovoRx stock? Short selling RNXT is an investing strategy that aims to generate trading profit from RenovoRx as its price is falling. RNXT shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against RenovoRx? A short squeeze for RenovoRx occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RNXT, which in turn drives the price of the stock up even further. How often is RenovoRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RNXT, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies ABOS Short Interest Data MGX Short Interest Data LPTX Short Interest Data TARA Short Interest Data INMB Short Interest Data XFOR Short Interest Data ADVM Short Interest Data CRDL Short Interest Data MNOV Short Interest Data DERM Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RNXT) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredSix Stocks That Could Soar on Trump’s First Day BackThe recent election results have clarified a path forward, creating opportunities that weren't as clear just m...InvestorPlace | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RenovoRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNXT Stock Alerts